Treatment with RMT3-23, a neutralizing antibody against T cell immunoglobulin domain and mucin domain-containing molecule-3 (Tim-3), decreases NLRC4 expression in IRI.309 This study suggests that Tim-3 mediates NLRC4 inflammasome activation in AKI. The gene discussed is NLRC4; the disease is acute kidney injury.